The market always puts potential value to a stock, before it is de-risked. Its called RISK ON valuation. And it represents a slice of risk off valuation.
When you drill for a billion barrels of oil target, you dont know if its water or oil. But the payday is so huge if its oil, that speculators take the risk on bet. Demand drives the price and valuation of that bet higher.
Everything has a potential Prize. The higher the prize, when the market actually understands what is at stake, the higher the demand for the risk on bet.
Although MRI might be the first horse out of the gates for utilising existing commercial hardware , long term, At $US1500 / test, application of both with MRX, add with another detail look at the area of interest with MRI, both using our NPs. Put that into the standard of care. And when MRX gets into a doctors office ?
And MRI has the choice between the old way, candles, or the new way smart light bulbs, sometimes you cant get that camel out of the tent, after its nose has got in. Forward calculate number of cancer types x number of tests (MRI + MRX) is the ultimate mountain peak from diagnostics. Add with what if treatments also utilise our targeting NPs piggyback.
When you become part of the standard of care, its a volumes $$$ gravy train. That forward prize, is what was so significant, that a speculative piece of it risk on, before phase 1 trials had even drawn to a freeze, propelled this to 200m mc.
IBX Price at posting:
2.6¢ Sentiment: Buy Disclosure: Held
